Allstate Investment Management’s Amgen AMGN Stock Holding History

Allstate Investment Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$6.66M	Buy	+25,360	New	+$6.8M	0.2%	69

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Allstate Investment Management's AMGN Position: Q4 2022 in Review

Allstate Investment Management opened a new position in Amgen (AMGN) in Q4 2022: 25,360 shares worth $6.66M. The stake represents 0.2% of the portfolio and ranks #69 among its holdings.

2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

Allstate Investment Management held 25,360 shares of Amgen worth $6.66M as of Q4 2022.
Amgen was a new Allstate Investment Management position in Q4 2022.
Amgen made up 0.2% of Allstate Investment Management's portfolio in Q4 2022, its #69 holding.
2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Allstate Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.